Dr. Enrique Grande Pulido
Address: Ruber Internacional Hospital Calle de la Masó, 38, Madrid, Madrid, Comunidad de, Spain
Gender: Male
About the Doctor / Professional
Dr. Enrique Grande is an internationally recognized medical oncologist and a leading expert in bladder cancer, genitourinary cancers, and neuroendocrine tumors. As the Director of the Medical Oncology Department and Director of the One Oncology Madrid Cancer Program at Quirónsalud, he leads a fully integrated, multidisciplinary oncology model dedicated to precision medicine, advanced molecular profiling, and pioneering clinical trials.
With a distinguished academic background—including a PhD "Cum Laude" and a Master's from the Spanish National Cancer Research Center (CNIO)—Dr. Grande has served as a principal investigator in over 100 international clinical trials and authored more than 300 peer-reviewed publications. He is a founding member of key oncology research groups, including GETHI and the GUARD Consortium, and serves as an associate editor for several prominent medical journals, making him a premier global key opinion leader in innovative cancer therapies.
Degree: PhD "Cum Laude" from the University of Alcalá
Residency: Hospital Clínico San Carlos in Madrid, Spain
- Director of the Medical Oncology Department at Quirónsalud
- Director of the One Oncology Madrid Cancer Program at Quirónsalud
- Head of Medical Oncology at MD Anderson Cancer Center Madrid
- Lead for translational and early-phase cancer research at Ramón y Cajal University Hospital
- Medical Oncology specialization residency at Hospital Clínico San Carlos
- Earned PhD "Cum Laude" from the University of Alcalá
- Founding member of the Spanish Group for Orphan and Rare Tumors (GETHI)
- Founding member of the Consortium for Research and Development in Genitourinary Tumors (GUARD Consortium)
- Board member of the Spanish Group for Neuroendocrine Tumors (GETNE)
- Recognized as an international key opinion leader across multiple oncology fields
- Served in a leadership role for more than 100 international clinical trials
- Authored over 300 clinical publications focused on bladder, kidney, prostate, and neuroendocrine tumors
- Serves on international pharmaceutical advisory committees for drug development
- Acts as an associate editor for prominent scientific publications, including Bladder Cancer, Future Oncology, World Journal of Clinical Oncology, and Gaceta Mexicana de Oncología
- Bladder Cancer Treatment
- Cancer/Oncology Consultation
- Chemotherapy
- Hormone Therapy for Cancer
- Immunotherapy
- Kidney Cancer Treatment
- Prostate Cancer Treatment
- Targeted Therapy
- Urological Oncology
- European Society for Medical Oncology
- American Society of Clinical Oncology
- European Neuroendocrine Tumor Society
- European Association of Urology
- Spanish Group for Orphan and Rare Tumors (GETHI)
- Spanish Group for Neuroendocrine Tumors (GETNE)
- Spanish Group for Genitourinary Tumors (SOGUG)
